08:00 , Jan 5, 2009 |  BC Week In Review  |  Clinical News

Alnylam preclinical data

Data published in Oligonucleotides showed that Alnylam's siRNAs, when delivered directly to the CNS in rodents, successfully silenced 2',3'-cyclic nucleotide 3' phosphodiesterase (CNPase) (CNP) mRNA by about 75% compared with control and was durable for...